Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05894265 · ClinicalTrials.gov registry record · NA

Prospective Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft Active Matrix (AM) vs. Standard of Care in Arthroscopic Rotator Cuff Repair

A NA study of Rotator Cuff Tears, sponsored by The University of Texas Health Science Center, Houston.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT05894265 is a NA study of Rotator Cuff Tears that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 60 participants, below the 1,278-participant average among 20 other Rotator Cuff Tears trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05894265, a NA study of Rotator Cuff Tears, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to see how well the ActiveMatrix® graft works at improving healing and function of the shoulder following rotator cuff repair surgery

Conditions Studied

Interventions

  • OTHER ActiveMatrix® Dosage A
  • OTHER ActiveMatrix® Dosage B
  • PROCEDURE Saline injection

Study Locations (1)

Texas

  • The University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2023-06-14
Est. Completion 2026-08-01
Phase NA

What the Registry Record Tells You About NCT05894265

The ClinicalTrials.gov registry entry for NCT05894265 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,278-participant average among 20 other Rotator Cuff Tears trials with a reported enrollment target (95% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rotator Cuff Tears appearing as the primary indexed condition, and to 3 interventions - of which ActiveMatrix® Dosage A is the first listed.

NCT05894265 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05894265 about?

NCT05894265 is a clinical study titled "Prospective Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft Active Matrix (AM) vs. Standard of Care in Arthroscopic Rotator Cuff Repair". The purpose of this study is to see how well the ActiveMatrix® graft works at improving healing and function of the shoulder following rotator cuff repair surgery

What is the current status of trial NCT05894265?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-06-14. Estimated completion is 2026-08-01.

What conditions does trial NCT05894265 study?

This clinical trial studies the following conditions: Rotator Cuff Tears.

What interventions are being tested in trial NCT05894265?

The interventions under investigation include: ActiveMatrix® Dosage A (OTHER), ActiveMatrix® Dosage B (OTHER), Saline injection (PROCEDURE).

Who is sponsoring clinical trial NCT05894265?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05894265 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rotator Cuff Tears

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.